Definium Therapeutics, Inc. · NASDAQ:DFTX
Commodore Capital LP's stake in Definium Therapeutics, Inc. fell to 1.80% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Commodore Capital LP's stake in Definium Therapeutics, Inc. fell to 1.80%, 2,410,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 1.80%
- Shares
- 2,410,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 1.80% | 2,410,000 |
| Commodore Capital Master LP | 1.80% | 2,410,000 |
| Robert Egen Atkinson | 1.80% | 2,410,000 |
| Michael Kramarz | 1.80% | 2,410,000 |
Source
Related
- Definium Therapeutics, Inc.
- Commodore Capital LP
- Definium Therapeutics, Inc. shareholders
- Schedule 13G/A · Commodore Capital LP · Feb 17, 2026
- Form 4 · Karlin Daniel · Sep 29, 2026
- Form 4 · Barrow Robert · Sep 29, 2026
- Form 4 · Wiley Matthew T. · Sep 29, 2026
- Form 4 · Sullivan Mark · Sep 29, 2026
- Form 4 · Roberts Brandi · Sep 29, 2026